Facet Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$643K Buy
10,305
+1,974
+24% +$125K 0.01% 200
2026
Q2
$480K Buy
8,331
+1,913
+30% +$110K 0.01% 220
2026
Q1
$389K Buy
+6,418
New +$374K 0.01% 208

Other funds holding BMY

Facet Wealth's BMY Position: Q3 2026 in Review

Facet Wealth increased its Bristol-Myers Squibb (BMY) stake by 24% in Q3 2026, buying an estimated $125K and bringing the position to 10,305 shares worth $643K. The position accounts for 0.01% of the portfolio, ranked #200.

Facet Wealth first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Facet Wealth held 10,305 shares of Bristol-Myers Squibb worth $643K as of Q3 2026.
  • Facet Wealth bought 1,974 Bristol-Myers Squibb shares in Q3 2026, an estimated $125K.
  • Bristol-Myers Squibb made up 0.01% of Facet Wealth's portfolio in Q3 2026, its #200 holding.
  • Facet Wealth first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Facet Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.